Comparison of Bivalirudin Versus Heparin for Anticoagulation During Extracorporeal Membrane Oxygenation
Hasegawa D, Sato R, Prasitlumkum N, Nishida K, Keaton B, Acquah SO, Im Lee Y (2022) · ASAIO Journal
Study Profile
- Design
- systematic review and random-effects meta-analysis of 11 observational studies (Embase, Cochrane Central, MEDLINE)
- Scope
- Bivalirudin anticoagulation in ECMO patients
- Main result
- Bivalirudin associated with significantly lower short-term mortality (OR 0.71, 95% CI 0.55-0.92, p=0.01, I²=7%) compared with heparin in ECMO patients
- PMID
- 36194483
Key Findings
- Mortality signal in favor of bivalirudin (OR 0.71, p=0.01)
- Low heterogeneity (I²=7%) supports robustness
- Adds quantitative mortality endpoint to ECMO anticoagulant literature
- Random-effects model used to account for clinical heterogeneity
- Calls for prospective RCT confirmation
Limitations
- All included studies observational
- Selection bias - bivalirudin often reserved for HIT or bleeding patients
- Variable anticoagulation monitoring strategies across studies
- Cannot establish causation
- Not applicable to whole-leech hirudotherapy
Clinical Implications
Hasegawa 2022 contributes a positive mortality signal to the broader bivalirudin ECMO evidence base. For ASH, the meta-analysis demonstrates how the synthetic thrombin inhibitor pathway generates emerging mortality signals under retrospective synthesis, structurally separate from the K040187 device-leech US clinical practice. The mortality finding warrants RCT confirmation.
Related studies
Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation
Huang D, Guan Q, Qin J, Shan R, Wu J, Zhang C (2022)
Heparin Versus Bivalirudin for Anticoagulation in Adult Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
Wieruszewski PM, Macielak SA, Nei SD, Moman RN, Seelhammer TG, Nabzdyk CGS, Gerberi DJ, Mara KC, Hooten WM, Wittwer ED (2022)
Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis
Li DH, Sun MW, Zhang JC, Zhang C, Deng L, Jiang H (2021)
Experience with pharmacologic leeching with bivalirudin for adjunct treatment of venous congestion of head and neck reconstructive flaps
Harun A, Kruer RM, Lee A, Boahene K, Byrne PJ, Richmon JD (2018)